[LGND] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
28-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- 1,041.45%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 277,133 186,419 120,282 251,453 141,102 108,973 71,914 25.18%
PBT 47,298 -10,538 796,639 173,330 57,231 7,960 35,329 4.97%
Tax -10,288 -7,553 167,337 30,009 44,675 10,327 -219,596 -39.93%
NP 57,138 -2,985 629,302 143,321 12,556 -1,636 257,305 -22.16%
Tax Rate 21.75% - -21.01% -17.31% -78.06% -129.74% 621.57% -
Total Cost 219,995 189,404 -509,020 108,132 128,546 110,609 -185,391 -
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 20.62 -1.60 523.19 57.00 8.90 -1.50 357.80 -37.82%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS 3.44 -0.18 33.13 5.96 0.60 -0.08 13.00 -19.85%
EPS Diluted 3.31 -0.18 31.85 5.96 0.53 -0.08 12.12 -19.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.